A citation-based method for searching scientific literature

Annette Haacke, Sarah A Broadley, Raina Boteva, Nikolay Tzvetkov, F Ulrich Hartl, Peter Breuer. Hum Mol Genet 2006
Times Cited: 93



Giuseppe Nicastro, Rajesh P Menon, Laura Masino, Philip P Knowles, Neil Q McDonald, Annalisa Pastore. Proc Natl Acad Sci U S A 2005
Times Cited: 138




List of shared articles



Times cited

Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner. J Neurosci 2006
114

Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Mário N Laço, Luisa Cortes, Sue M Travis, Henry L Paulson, A Cristina Rego. PLoS One 2012
16


Conformational diseases: structural studies of aggregation of polyglutamine proteins.
Elena Papaleo, Gaetano Invernizzi. Curr Comput Aided Drug Des 2011
10

Identification and functional dissection of localization signals within ataxin-3.
Paul Michel Aloyse Antony, Simone Mäntele, Phillip Mollenkopf, Jana Boy, Ralph H Kehlenbach, Olaf Riess, Thorsten Schmidt. Neurobiol Dis 2009
33

Ataxin-3 is subject to autolytic cleavage.
Pier Luigi Mauri, Matteo Riva, Daniela Ambu, Antonella De Palma, Francesco Secundo, Louise Benazzi, Marco Valtorta, Paolo Tortora, Paola Fusi. FEBS J 2006
22


CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.
V Pastori, E Sangalli, P Coccetti, C Pozzi, S Nonnis, G Tedeschi, P Fusi. Biochim Biophys Acta 2010
15

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
157

Study of subcellular localization and proteolysis of ataxin-3.
Chiara Pozzi, Marco Valtorta, Gabriella Tedeschi, Elena Galbusera, Valentina Pastori, Alessandra Bigi, Simona Nonnis, Eleonora Grassi, Paola Fusi. Neurobiol Dis 2008
44

Conformational behavior and aggregation of ataxin-3 in SDS.
Helen M Saunders, Victoria A Hughes, Roberto Cappai, Stephen P Bottomley. PLoS One 2013
6


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
89

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
48

PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.
Hui Yang, Hong-Wei Yue, Wen-Tian He, Jun-Ye Hong, Lei-Lei Jiang, Hong-Yu Hu. FASEB J 2018
15

Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Clévio Nóbrega, Ana Teresa Simões, Joana Duarte-Neves, Sónia Duarte, Ana Vasconcelos-Ferreira, Janete Cunha-Santos, Dina Pereira, Magda Santana, Cláudia Cavadas, Luís Pereira de Almeida. Adv Exp Med Biol 2018
9

SCA3: neurological features, pathogenesis and animal models.
Olaf Riess, Udo Rüb, Annalisa Pastore, Peter Bauer, Ludger Schöls. Cerebellum 2008
149

A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Veronica F Colomer Gould, Daniel Goti, Donna Pearce, Guillermo A Gonzalez, Hong Gao, Mario Bermudez de Leon, Nancy A Jenkins, Neal G Copeland, Christopher A Ross, Dale R Brown. Neurobiol Dis 2007
39